NIH-funded research R01 grant

How stopping vaginal washing affects cervical inflammation and HIV risk in women from sub-Saharan Africa.

Official title: The impact of vaginal washing on cervical inflammation: a randomized controlled trial of women from sub-Saharan Africa at high risk for HIV acquisition.

Funded at University of Washington · NIH-10922193 · Data updated 2026-11-12

This study is looking at how vaginal washing might affect inflammation in the cervix and whether that could increase the risk of HIV for women in sub-Saharan Africa, and it will help us understand if stopping this practice makes a difference in their health.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 16, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$721,486
NIH project number1R01HD115465-01
Project IDNIH-10922193 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women from sub-Saharan Africa who regularly practice vaginal washing and are at high risk for HIV acquisition.

Less likely to help

Patients who do not practice vaginal washing or who are not at risk for HIV may not benefit from this research.

What this research studies

This research investigates the effects of vaginal washing on cervical inflammation and its potential link to increased HIV risk among women in sub-Saharan Africa. The study will involve a randomized controlled trial where participants will either cease vaginal washing or continue their usual practices. Researchers will measure changes in inflammatory markers and immune cell concentrations in cervical fluid and tissue, as well as the presence of protective bacteria. The goal is to understand how these biological changes may influence susceptibility to HIV.

Why it matters

Potential benefit: If successful, this research could lead to improved reproductive health strategies that reduce the risk of HIV acquisition in women.

How similar studies have gone: While some studies have explored the relationship between vaginal practices and HIV risk, this specific approach to examining the cessation of vaginal washing is novel and has not been extensively tested.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Sabo, Michelle Catherine — University of Washington
  • Study coordinator: Sabo, Michelle Catherine

Related research

Other NIH-funded projects on the same topics.

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

  • Shorter antifungal course for kids with candidemia

    A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606502

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.